DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,798 filers reported holding DANAHER CORPORATION in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $227,157 | +94156.0% | 954 | -3.1% | 0.10% | -1.0% |
| Q1 2023 | $241 | -6.9% | 985 | 0.0% | 0.10% | -18.3% |
| Q4 2022 | $259 | -100.0% | 985 | -67.4% | 0.12% | -69.4% |
| Q3 2022 | $813,000 | +7.0% | 3,026 | +1.0% | 0.39% | +5.4% |
| Q2 2022 | $760,000 | -16.8% | 2,996 | -3.9% | 0.37% | -2.1% |
| Q1 2022 | $914,000 | +7.8% | 3,116 | +21.0% | 0.38% | +8.0% |
| Q4 2021 | $848,000 | +16.6% | 2,576 | +7.9% | 0.35% | +6.0% |
| Q3 2021 | $727,000 | +12.0% | 2,387 | -1.3% | 0.33% | +8.9% |
| Q2 2021 | $649,000 | +21.1% | 2,418 | +1.5% | 0.30% | +12.1% |
| Q1 2021 | $536,000 | +5.5% | 2,382 | +4.2% | 0.27% | -1.8% |
| Q4 2020 | $508,000 | -5.8% | 2,285 | -8.7% | 0.28% | -19.5% |
| Q3 2020 | $539,000 | +19.2% | 2,504 | -2.0% | 0.34% | +7.8% |
| Q2 2020 | $452,000 | -8.7% | 2,554 | -28.6% | 0.32% | -22.2% |
| Q1 2020 | $495,000 | -8.5% | 3,575 | +1.4% | 0.41% | +2.2% |
| Q4 2019 | $541,000 | -1.3% | 3,525 | -7.1% | 0.40% | -7.0% |
| Q3 2019 | $548,000 | +3.6% | 3,796 | +2.6% | 0.43% | -2.0% |
| Q2 2019 | $529,000 | +10.4% | 3,701 | +2.0% | 0.44% | +4.8% |
| Q1 2019 | $479,000 | +34.6% | 3,627 | +5.1% | 0.42% | +21.0% |
| Q4 2018 | $356,000 | – | 3,451 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |